(Q44227098)

1 December 2017

title

Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/B non-small cell lung cancer (English)

1 reference

1 December 2017

author name string

Maximiliano Van Kooten

1

1 reference

1 December 2017

Moisés Rosenberg

2

1 reference

1 December 2017

Mauro Orlando

3

1 reference

1 December 2017

José Morero

4

1 reference

1 December 2017

Manuel Vilanova

5

1 reference

1 December 2017

Oscar Rojas

6

1 reference

1 December 2017

Héctor Vicente

7

1 reference

1 December 2017

Claudia Bagnes

8

1 reference

1 December 2017

Carlos Silva

9

1 reference

1 December 2017

Reinaldo D Chacón

10

1 reference

1 December 2017

publication date

1 November 2002

1 reference

Investigational New Drugs

1 December 2017

published in

1 reference

1 December 2017

volume

20

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

439-446

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1020618313969

1 December 2017

exact match

0 references

cites work

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

12 December 2020

Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group

1 reference

12 December 2020

Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery

1 reference

12 December 2020

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

1 reference

12 December 2020

A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis

1 reference

12 December 2020

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

12 December 2020

Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial

1 reference

12 December 2020

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

1 reference

12 December 2020

Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).

1 reference

12 December 2020

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial

1 reference

12 December 2020

Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study

1 reference

12 December 2020

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

1 reference

12 December 2020

Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients

1 reference

12 December 2020

Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Revisions in the International System for Staging Lung Cancer

1 reference

12 December 2020

Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial

1 reference

12 December 2020

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

1 reference

12 December 2020

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

1 reference

12 December 2020

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Future directions in the treatment of non-small cell lung cancer

1 reference

12 December 2020

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

12 December 2020

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

12 December 2020

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

12 December 2020

Randomized trial of neoadjuvant therapy for lung cancer: interim analysis

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020618313969

1 reference

Dimensions Publication ID

1 December 2017

1019649498

0 references

1 reference